Discussion about this post

User's avatar
Leslie Loftis's avatar

I came here to make a similar comment to Grace. I will add that because of fertility women not only make ethically and chemically tricky test subjects, but also they make liability-fraught test subjects. The ethical problems can quickly slide into a legal problems. It is a tricky problem to solve because the researchers would need to disclose all of the potential foreseen risks and mention the unseen risks, which would likely repel most women who are pregnant or likely to get pregnant. And the researchers certainly wouldn't want subjects to get pregnant as the secondary liability for any harm to the child could be astronomical. (Think thalidomide, because that's what the researchers' lawyers will have in their heads as worst case scenarios.)

Researchers could pay upfront for the risk, but then the few women likely to consent to any sort of risk are those who are in extreme need of money. It becomes exploitive. (Think surrogacy markets.)

Expand full comment
Catherine H Harrell's avatar

I have met people affected by the drug thaliomide, intended to prevent nausea in pregnant women, so I understand the concern about using pregnant women in drug trials. However, not using women at all or in limited numbers in trials is just as risky. It is the reason I participated in the Pfizer trial for COVID. Many of my friends thought I was crazy, but if no one participates then there is no vaccine. I hope that I represented post-menopausal women ( I am 57).

Expand full comment
31 more comments...

No posts